DRUG
NASDAQ · Biotechnology
Bright Minds Biosciences Inc
$60.66
+1.14 (+1.92%)
Open$61.22
Previous Close$59.52
Day High$62.55
Day Low$59.00
52W High$170.00
52W Low$33.01
Volume—
Avg Volume690
Market Cap839.37M
P/E Ratio—
EPS$-3.40
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
-55.6% upside
Current
$60.66
$60.66
Target
$26.95
$26.95
$16.82
$26.95 avg
$32.06
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 177.09M | 163.76M | 147.32M |
| Net Income | 34.74M | 43.56M | 40.99M |
| Profit Margin | 19.6% | 26.6% | 27.8% |
| EBITDA | 73.10M | 70.32M | 54.60M |
| Free Cash Flow | 20.82M | 31.20M | 18.21M |
| Rev Growth | -5.5% | +4.9% | +20.1% |
| Debt/Equity | 0.67 | 0.83 | 0.74 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |